February 27, 2018 / 6:09 AM / 6 months ago

BRIEF-Vistin Pharma Q4 Adjusted EBITDA Loss Widens To NOK ‍1.6​ Million

Feb 27 (Reuters) - VISTIN PHARMA ASA:

* Q4 REVENUE NOK ‍41.6​ MILLION VERSUS NOK 32.5 MILLION YEAR AGO

* Q4 ADJUSTED EBITDA LOSS FROM CONTINUING. OPERATIONS NOK ‍1.6​ MILLION VERSUS LOSS NOK 1.0 MILLION YEAR AGO

* THE BOARD WILL PROPOSE A DIVIDEND OF NOK 17.1 MILLION (NOK 1.00 PER SHARE) FOR 2017‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below